Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferroptosis as a potential target for cancer therapy
Zhen Chen, Weilong Wang, Siti Razila Abdul Razak, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy
Chloe Springer, Danish Humayun, Rachid Skouta
Cancers (2024) Vol. 16, Iss. 3, pp. 647-647
Open Access | Times Cited: 21
Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 20
Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology
Muhammad Hossein Ashoub, Razieh Razavi, Kamran Heydaryan, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
Antioxidant Systems as Modulators of Ferroptosis: Focus on Transcription Factors
Carolina Punziano, Silvia Trombetti, Elena Cesaro, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 298-298
Open Access | Times Cited: 15
In defence of ferroptosis
Francesca M. Alves, Darius J.R. Lane, Triet Phu Minh Nguyen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence
Shuman Zhen, Yunlong Jia, Yan Zhao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Reversible Dual Fluorescence-Lifetime Imaging of Mitochondrial GSH and Microviscosity: Real-Time Evaluation of Ferroptosis Status
Siyu Wang, Yuchen Qu, Na Shao, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 11, pp. 4570-4579
Closed Access | Times Cited: 12
Polyunsaturated fatty acids-induced ferroptosis suppresses pancreatic cancer growth
Akane Suda, Banlanjo Abdulaziz Umaru, Yui Yamamoto, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Pioneering the future of cancer therapy: Deciphering the p53-ferroptosis nexus for precision medicine
Daiha Shin, Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2024) Vol. 585, pp. 216645-216645
Closed Access | Times Cited: 10
Redox-regulating nanotherapeutics potentiating ferroptosis-driven cancer treatment
Xiaohong Yang, Xinxin Sun, Jin Lei, et al.
Chemical Engineering Journal (2024) Vol. 484, pp. 149518-149518
Closed Access | Times Cited: 10
Iron toxicity, ferroptosis and microbiota in Parkinson’s disease: Implications for novel targets
Fernanda V. Carvalho, Harold E. Landis, Bruk Getachew, et al.
Advances in neurotoxicology (2024), pp. 105-132
Open Access | Times Cited: 9
Cell death signaling in human erythron: erythrocytes lose the complexity of cell death machinery upon maturation
Anton Tkachenko, Ondřej Havránek
APOPTOSIS (2025)
Open Access | Times Cited: 1
Ferroptosis and circular RNAs: new horizons in cancer therapy.
Asif Ahmad Bhat, Neelima Kukreti, Muhammad Afzal, et al.
PubMed (2024) Vol. 23, pp. 570-599
Closed Access | Times Cited: 7
Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids
Marwa M. Abu‐Serie
Nanomedicine (2024) Vol. 19, Iss. 11, pp. 979-994
Closed Access | Times Cited: 6
FETPY: a Diiron(I) Thio–Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo
Ekatarina Mihajlović, Lorenzo Biancalana, Sanja Jelača, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7553-7568
Open Access | Times Cited: 6
Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance
Celine Kapper, Peter Oppelt, Barbara Arbeithuber, et al.
Life Sciences (2024) Vol. 349, pp. 122720-122720
Open Access | Times Cited: 6
Ferroptosis: a new regulatory mechanism in neuropathic pain
Lu Li, Lingling Guo, Rui Gao, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 14
Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
Roberta Veglia Tranchese, Sabrina Battista, Laura Cerchia, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1443-1443
Open Access | Times Cited: 5
Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications
Kiavash Hushmandi, Daniel J. Klionsky, Amir Reza Aref, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1159-1177
Open Access | Times Cited: 4
Immunometabolism of ferroptosis in the tumor microenvironment
Gian Luca Lupica-Tondo, Emily N. Arner, Denis A. Mogilenko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Regulation and therapy: the role of ferroptosis in DLBCL
Yifan Wang, Zhengmei He, Xinyu Dong, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Hacia una nueva comprensión de la ferroptosis
Juan Carlos Restrepo
Hepatología (2025) Vol. 6, Iss. 1, pp. 11-12
Closed Access
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
Murshid Imam, Jiale Ji, Zhijie Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Targeting ferroptosis in gastrointestinal tumors: Interplay of iron-dependent cell death and autophagy
Majid Safari, Payman Rahimzadeh, Elmira Alaei, et al.
Molecular and Cellular Probes (2025) Vol. 79, pp. 102013-102013
Closed Access
Circular RNA circBNC2 inhibits tumorigenesis by modulating ferroptosis and acts as a nanotherapeutic target in prostate cancer
Xiang Pan, Kaiwen Chen, Wei Gao, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top